glp-1 shortage us North Carolina among the states with high rates of Ozempic prescriptions 📣 Important GLP1 Update from

GLP-1 Agonists Side Effects & Risks GLP-1 agonist treatment has a high safety profile and is FDA-approved

Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials

In a 52-week phase II trial involving patients with MASH and advanced fibrosis, tirzepatide demonstrated dose-dependent benefits in resolving MASH, with the highest dose achieving a resolution rate of 62%

Insurance companies typically do not cover OFF LABEL prescribing of FDA approved for type 2 diabetes for weight loss without a type 2 diabetes diagnosis

Your Next Steps Neither medication is magic